Synthetic cathinones are a rapidly evolving class of substances derived from the khat plant.

Synthetic cathinones are a rapidly evolving class of substances derived from the khat plant.
Image: Intellect (generated)

In short: Derived from the natural alkaloid cathinone found in the Catha edulis shrub, synthetic cathinones are beta-keto analogs of amphetamine. These substances have become a major category of new psychoactive substances, often marketed as bath salts or research chemicals, posing significant public health risks due to their potent stimulant effects.

Cathinone is a monoamine alkaloid naturally occurring in the khat plant, which has been cultivated for millennia in the Horn of Africa and the Arabian Peninsula. While khat was traditionally used for its mild stimulant properties, researchers identified cathinone as the primary active ingredient in the 1970s. It functions as a norepinephrine-dopamine releasing agent, crossing the blood-brain barrier to stimulate the release of dopamine while inhibiting the reuptake of various neurotransmitters. Unlike many synthetic variants, cathinone acts as a weak agonist of the trace amine-associated receptor 1, which may help constrain its overall monoaminergic effects.

The illicit market for synthetic cathinones emerged in the early 2000s, as chemists exploited the molecule's flexible backbone structure to create a wide array of derivatives. By modifying the aromatic ring, alkyl side chain, or amino groups, labs produced substances like mephedrone, MDPV, and methylone. These compounds were initially developed for potential therapeutic use as antidepressants or appetite suppressants but were quickly repurposed as recreational drugs. Their popularity surged as they were sold online under labels like plant food, though their misuse led to severe toxicity and fatalities, prompting international regulatory crackdowns.

Despite these controls, the market has proven remarkably resilient. When specific substances like mephedrone were banned in 2010, they were rapidly replaced by dozens of new derivatives. Between 2012 and 2015, 69 new synthetic cathinone derivatives appeared on the market, with 2014 seeing a peak of 31 new substances. Today, the broader category of new psychoactive substances has stabilized, with hundreds of compounds reported annually. This constant structural innovation continues to challenge public health initiatives, as authorities struggle to manage the risks posed by substances that are frequently updated to circumvent existing drug legislation.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-cathinone.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…